Dermata Therapeutics, Inc. (DRMA) KPIs and segments

DRMANasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30

$0.62−0.04 (-6.01%)

Close on Nov 13, 2026Market cap $2.50MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Dermata Therapeutics's business

Coming soon

This tab will track the numbers specific to Dermata Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?